Question 1

What’s the financial overview for 2196.HK?

Accepted Answer

2196.HK’s market cap stands at HK$0.07 trillion right now. The company’s trailing twelve-month earnings per share EPS is HK$1.20, with a dividend yield of 1.97%. Their next earnings report is set for January 29, 2025, and the estimated EPS for that period is $1.61. You can also check out summaries of their income statement, balance sheet, and cash flow details for a fuller picture of their financials.

Question 2

How can I analyze historical data?

Accepted Answer

To analyze historical data with AI tools, apply the date range filter above the table to focus on a specific period. The table displays daily open, high, low, close prices, and volume, enabling you to spot trends and patterns. Use these insights to make informed decisions based on historical performance.

Question 3

What does 2196.HK Stock ROE tell us?

Accepted Answer

2196.HK stock ROE shows positive market sentiment. A higher ROE means the company’s management is doing a better job at using equity financing to drive income and growth. It’s a handy metric for comparing how a company stacks up against its competitors or the broader market.

Question 4

What is per share price for 2196.HK?

Accepted Answer

The 2196.HK stock per share price is HK$16.38.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024
Revenue	$10.16B	$10.45B	$10.23B	$10.06B
Cost of Revenue	$5.48B	$5.43B	$5.74B	$5.08B
Gross Profit	$4.68B	$5.02B	$4.50B	$4.99B
Gross Profit Ratio	$0.46	$0.48	$0.44	$0.50
R&D Expenses	$996.32M	$786.30M	$937.02M	$829.57M
SG&A Expenses	$3.23B	$6.60B	$2.85B	$3.26B
Operating Expenses	$3.54B	$3.84B	$3.82B	$4.08B
Total Costs & Expenses	$9.02B	$9.27B	$9.55B	$9.16B
Interest Income	$93.50M	$90.74M	$304.51M	$87.14M
Interest Expense	$364.04M	$358.33M	$361.45M	$348.09M
Depreciation & Amortization	$0.00	$320.39M	$756.64M	$663.29M
EBITDA	$1.46B	$1.50B	$1.27B	$1.79B
EBITDA Ratio	$0.14	$0.14	$0.12	$0.18
Operating Income	$1.14B	$1.18B	$680.04M	$904.51M
Operating Income Ratio	$0.11	$0.11	$0.07	$0.09
Other Income/Expenses (Net)	-$39.80M	-$37.94M	-$278.26M	-$2.94M
Income Before Tax	$1.10B	$1.14B	$401.78M	$688.10M
Income Before Tax Ratio	$0.11	$0.11	$0.04	$0.07
Income Tax Expense	$103.79M	$171.58M	$149.27M	$232.20M
Net Income	$759.24M	$785.84M	$615.06M	$609.73M
Net Income Ratio	$0.07	$0.08	$0.06	$0.06
EPS	$0.29	$0.30	$0.23	$0.23
Diluted EPS	$0.29	$0.30	$0.23	$0.23
Weighted Avg Shares Outstanding	$2.66B	$2.66B	$2.67B	$2.67B
Weighted Avg Shares Outstanding (Diluted)	$2.66B	$2.66B	$2.67B	$2.67B

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.